RIM
Rakuten Investment Management Portfolio holdings
AUM
$21.8B
This Quarter Return
-3.54%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$21.8B
AUM Growth
–
Cap. Flow
+$21.8B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
80.98%
Holding
694
New
694
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Vanguard Total Stock Market ETF
VTI
|
+$12.4B |
| 2 |
Vanguard Total World Stock ETF
VT
|
+$1.81B |
| 3 |
Schwab US Dividend Equity ETF
SCHD
|
+$911M |
| 4 |
Vanguard Total International Stock ETF
VXUS
|
+$838M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$403M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 7.68% |
| 2 | Financials | 2.7% |
| 3 | Consumer Discretionary | 2.46% |
| 4 | Healthcare | 2.37% |
| 5 | Communication Services | 2.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Gaming and Leisure Properties
GLPI
$13.7B
| $382K | ﹤0.01% |
+7,571
| New | +$382K |
|
602
Amkor Technology
AMKR
$6.27B
| $381K | ﹤0.01% |
+20,837
| New | +$381K |
|
603
Mohawk Industries
MHK
$8.68B
| $380K | ﹤0.01% |
+3,343
| New | +$380K |
|
604
W.P. Carey
WPC
$15B
| $379K | ﹤0.01% |
+6,039
| New | +$379K |
|
605
BioMarin Pharmaceuticals
BMRN
$10.7B
| $376K | ﹤0.01% |
+5,259
| New | +$376K |
|
606
Booz Allen Hamilton
BAH
$12.8B
| $371K | ﹤0.01% |
+3,526
| New | +$371K |
|
607
Toast
TOST
$23.8B
| $371K | ﹤0.01% |
+11,047
| New | +$371K |
|
608
United Therapeutics
UTHR
$18.3B
| $359K | ﹤0.01% |
+1,170
| New | +$359K |
|
609
Illumina
ILMN
$15.3B
| $350K | ﹤0.01% |
+4,376
| New | +$350K |
|
610
Caesars Entertainment
CZR
$5.39B
| $348K | ﹤0.01% |
+13,558
| New | +$348K |
|
611
American Homes 4 Rent
AMH
$12.8B
| $344K | ﹤0.01% |
+9,160
| New | +$344K |
|
612
KE Holdings
BEKE
$23.8B
| $344K | ﹤0.01% |
+16,703
| New | +$344K |
|
613
Aecom
ACM
$16.9B
| $339K | ﹤0.01% |
+3,660
| New | +$339K |
|
614
Owens Corning
OC
$13.2B
| $338K | ﹤0.01% |
+2,367
| New | +$338K |
|
615
Equity Lifestyle Properties
ELS
$11.9B
| $333K | ﹤0.01% |
+5,008
| New | +$333K |
|
616
Vanguard Total Bond Market
BND
$135B
| $332K | ﹤0.01% |
+4,533
| New | +$332K |
|
617
Royalty Pharma
RPRX
$15.9B
| $327K | ﹤0.01% |
+10,420
| New | +$327K |
|
618
HEICO
HEI
$44.7B
| $323K | ﹤0.01% |
+1,214
| New | +$323K |
|
619
Dick's Sporting Goods
DKS
$20.7B
| $323K | ﹤0.01% |
+1,598
| New | +$323K |
|
620
Annaly Capital Management
NLY
$14.2B
| $320K | ﹤0.01% |
+15,467
| New | +$320K |
|
621
Manhattan Associates
MANH
$13.3B
| $317K | ﹤0.01% |
+1,830
| New | +$317K |
|
622
Neurocrine Biosciences
NBIX
$14.2B
| $316K | ﹤0.01% |
+2,794
| New | +$316K |
|
623
Credicorp
BAP
$21.2B
| $305K | ﹤0.01% |
+1,620
| New | +$305K |
|
624
Avantor
AVTR
$8.87B
| $304K | ﹤0.01% |
+18,780
| New | +$304K |
|
625
Ovintiv
OVV
$10.9B
| $303K | ﹤0.01% |
+7,183
| New | +$303K |
|